Dollar-a-dose, off-patent drug being marketed in the US for $89000 as a muscular dystrophy treatment – Boing Boing
Business Wire |
Dollar-a-dose, off-patent drug being marketed in the US for $89000 as a muscular dystrophy treatment
Boing Boing Deflazacort, a steroid, can be purchased online from non-US sources for $1.00, but now it’s being marketed by Illinois’s Marathon Pharmaceuticals for $89,000 as Emflaza, to treat Duchenne muscular dystrophy, which predominantly affects men in their 20s. Marathon Pharmaceuticals to charge $89000 for muscular dystrophy drug after 70-fold increase An old drug gets a new price to fight a rare disease: $89000 a year Drug Company Jacks up Price of Old Drug by More Than 7000% |
View original article
Author:
Powered by WPeMatico
Health Topic Contributor
Editors and curators bringing you the latest and most impactful health news. Truly objective, we print links to stories and studies that may contradict one another. If you're searching for news on health studies, alternative health modalities, facts on modern allopathic medicine, and more, we're you're team bringing you the stories and facts that matter.